{"id":"https://openalex.org/W4403207804","doi":"https://doi.org/10.1186/s12883-024-03888-6","title":"Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies","display_name":"Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies","publication_year":2024,"publication_date":"2024-10-08","ids":{"openalex":"https://openalex.org/W4403207804","doi":"https://doi.org/10.1186/s12883-024-03888-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/39379875","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11460132"},"language":"en","primary_location":{"id":"doi:10.1186/s12883-024-03888-6","doi":"https://doi.org/10.1186/s12883-024-03888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12883-024-03888-6","pdf_url":"https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03888-6","source":{"id":"https://openalex.org/S120289491","display_name":"BMC Neurology","issn_l":"1471-2377","issn":["1471-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03888-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079130521","display_name":"Robert Zivadinov","orcid":"https://orcid.org/0000-0002-7799-1485","observed_orcids":["https://orcid.org/0000-0002-7799-1485"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Zivadinov","raw_affiliation_strings":["Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA","Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA","institution_ids":["https://openalex.org/I63190737"]},{"raw_affiliation_string":"Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091786784","display_name":"Alexander Keenan","orcid":"https://orcid.org/0009-0006-4805-7606","observed_orcids":["https://orcid.org/0009-0006-4805-7606"]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexander J. Keenan","raw_affiliation_strings":["Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA. AKeenan1@its.jnj.com","Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA. AKeenan1@its.jnj.com","institution_ids":["https://openalex.org/I4391767992"]},{"raw_affiliation_string":"Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109488109","display_name":"Hoa H. Le","orcid":"https://orcid.org/0009-0003-5249-8904","observed_orcids":["https://orcid.org/0009-0003-5249-8904","https://orcid.org/0000-0001-6755-1331"]},"institutions":[{"id":"https://openalex.org/I4391767992","display_name":"Janssen Scientific Affairs (United States)","ror":"https://ror.org/04w4xsz15","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4391767992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hoa H. Le","raw_affiliation_strings":["Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USA","institution_ids":["https://openalex.org/I4391767992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063149364","display_name":"Maria Ait-Tihyaty","orcid":"https://orcid.org/0000-0002-1983-4334","observed_orcids":["https://orcid.org/0000-0002-1983-4334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Ait-Tihyaty","raw_affiliation_strings":["Janssen Pharmaceuticals, Titusville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceuticals, Titusville, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081536368","display_name":"Kavita Gandhi","orcid":"https://orcid.org/0000-0002-4521-2467","observed_orcids":["https://orcid.org/0000-0002-4521-2467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kavita Gandhi","raw_affiliation_strings":["Janssen Pharmaceuticals, Titusville, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceuticals, Titusville, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088104237","display_name":"Matthew L. Zierhut","orcid":"https://orcid.org/0000-0002-5221-9157","observed_orcids":["https://orcid.org/0000-0002-5221-9157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew L. Zierhut","raw_affiliation_strings":["Certara USA, Inc., Radnor, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara USA, Inc., Radnor, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022103583","display_name":"Elizabeth M. Salvo\u2010Halloran","orcid":"https://orcid.org/0000-0002-1850-9855","observed_orcids":["https://orcid.org/0000-0002-1850-9855"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elizabeth M. Salvo-Halloran","raw_affiliation_strings":["EVERSANA, Value & Evidence Services, Burlington, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1850-9855","affiliations":[{"raw_affiliation_string":"EVERSANA, Value & Evidence Services, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012300936","display_name":"Abril Oliva Ramirez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Abril Oliva Ramirez","raw_affiliation_strings":["EVERSANA, Value & Evidence Services, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Value & Evidence Services, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023810505","display_name":"Vivian Vuong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vivian Vuong","raw_affiliation_strings":["EVERSANA, Value & Evidence Services, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Value & Evidence Services, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103710224","display_name":"Sumeet R. Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sumeet Singh","raw_affiliation_strings":["EVERSANA, Value & Evidence Services, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Value & Evidence Services, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060373660","display_name":"Brian Hutton","orcid":"https://orcid.org/0000-0001-5662-8647","observed_orcids":["https://orcid.org/0000-0001-5662-8647"]},"institutions":[{"id":"https://openalex.org/I4388482656","display_name":"Ottawa Hospital Research Institute","ror":"https://ror.org/05jtef216","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I153718931","https://openalex.org/I2800722420","https://openalex.org/I4388482656"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brian Hutton","raw_affiliation_strings":["Ottawa Hospital Research Institute, Ottawa, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Hospital Research Institute, Ottawa, ON, Canada","institution_ids":["https://openalex.org/I4388482656"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5091786784"],"corresponding_institution_ids":["https://openalex.org/I4391767992"],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":{"value":2890,"currency":"USD","value_usd":2890},"fwci":2.1323,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.86661504,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"24","issue":"1","first_page":"378","last_page":"378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brain-atrophy","display_name":"brain atrophy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.843999981880188},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":0.921999990940094},{"id":"https://openalex.org/keywords/ozanimod","display_name":"ozanimod","score":0.9990000128746033},{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":1.0},{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":1.0},{"id":"https://openalex.org/keywords/ponesimod","display_name":"ponesimod","score":0.9950000047683716},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.7549999952316284},{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":1.0},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8098322153091431},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7874848246574402},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.773222029209137},{"id":"https://openalex.org/C12770488","wikidata":"https://www.wikidata.org/wiki/Q188449","display_name":"Neurosurgery","level":2,"score":0.7397148013114929},{"id":"https://openalex.org/C39920043","wikidata":"https://www.wikidata.org/wiki/Q786278","display_name":"Neurochemistry","level":3,"score":0.7070656418800354},{"id":"https://openalex.org/C2991673738","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Brain disease","level":3,"score":0.5107502937316895},{"id":"https://openalex.org/C65835030","wikidata":"https://www.wikidata.org/wiki/Q1030681","display_name":"Brain size","level":3,"score":0.4916549324989319},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4784431755542755},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35215848684310913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30535557866096497},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.21228674054145813},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1692613661289215},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.15975332260131836},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.14004668593406677},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.11416339874267578}],"mesh":[{"descriptor_ui":"D000068876","descriptor_name":"Fingolimod Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12883-024-03888-6","doi":"https://doi.org/10.1186/s12883-024-03888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12883-024-03888-6","pdf_url":"https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03888-6","source":{"id":"https://openalex.org/S120289491","display_name":"BMC Neurology","issn_l":"1471-2377","issn":["1471-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Neurology","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-3611288/v1","doi":"https://doi.org/10.21203/rs.3.rs-3611288/v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21203/rs.3.rs-3611288/v1","pdf_url":"https://www.researchsquare.com/article/rs-3611288/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:11460132","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11460132","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11460132/pdf/12883_2024_Article_3888.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Neurol","raw_type":"Text"},{"id":"pmid:39379875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39379875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC neurology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:97264d5b987049ffa4492a729b163739","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/97264d5b987049ffa4492a729b163739","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Neurology, Vol 24, Iss 1, Pp 1-12 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12883-024-03888-6","doi":"https://doi.org/10.1186/s12883-024-03888-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12883-024-03888-6","pdf_url":"https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03888-6","source":{"id":"https://openalex.org/S120289491","display_name":"BMC Neurology","issn_l":"1471-2377","issn":["1471-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320337601","display_name":"Janssen Pharmaceuticals","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403207804.pdf","grobid_xml":"https://content.openalex.org/works/W4403207804.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W246286872","https://openalex.org/W1504183466","https://openalex.org/W1942328128","https://openalex.org/W1966561347","https://openalex.org/W2004474087","https://openalex.org/W2005947177","https://openalex.org/W2007567206","https://openalex.org/W2031210704","https://openalex.org/W2037636284","https://openalex.org/W2046748764","https://openalex.org/W2083674804","https://openalex.org/W2095707498","https://openalex.org/W2105167551","https://openalex.org/W2113144077","https://openalex.org/W2123968065","https://openalex.org/W2125776201","https://openalex.org/W2129821518","https://openalex.org/W2139204856","https://openalex.org/W2147273136","https://openalex.org/W2150529573","https://openalex.org/W2151576334","https://openalex.org/W2155772830","https://openalex.org/W2156098321","https://openalex.org/W2164282396","https://openalex.org/W2299177375","https://openalex.org/W2302260618","https://openalex.org/W2506374602","https://openalex.org/W2616379431","https://openalex.org/W2650689221","https://openalex.org/W2768618502","https://openalex.org/W2800924304","https://openalex.org/W2901936354","https://openalex.org/W2906720084","https://openalex.org/W2937912490","https://openalex.org/W2950296939","https://openalex.org/W2956790801","https://openalex.org/W2962068677","https://openalex.org/W3011340088","https://openalex.org/W3094115567","https://openalex.org/W3156339338","https://openalex.org/W4205851341","https://openalex.org/W4212778699","https://openalex.org/W4283764710","https://openalex.org/W4294215472","https://openalex.org/W4379093489"],"related_works":["https://openalex.org/W4415147287","https://openalex.org/W2034685098","https://openalex.org/W4372330945","https://openalex.org/W4386314499","https://openalex.org/W2594840221","https://openalex.org/W4415496510","https://openalex.org/W4389374158","https://openalex.org/W2066059319","https://openalex.org/W1982614515","https://openalex.org/W3138003291"],"abstract_inverted_index":{"BACKGROUND:":[0],"Brain":[1],"volume":[2],"loss":[3],"(BVL)":[4],"has":[5],"been":[6],"identified":[7],"as":[8],"a":[9,47,83,96,206,244],"predictor":[10],"of":[11,61,76,181,189,194,208,228,232,247],"disability":[12,239],"progression":[13],"in":[14,39,63,220,230],"relapsing":[15],"multiple":[16],"sclerosis":[17],"(RMS).":[18],"As":[19],"many":[20],"available":[21],"disease-modifying":[22],"treatments":[23],"(DMTs)":[24],"have":[25],"shown":[26],"an":[27,35],"effect":[28],"on":[29,78],"slowing":[30],"BVL,":[31],"this":[32,45],"is":[33,234],"becoming":[34],"emerging":[36],"clinical":[37,41,210],"endpoint":[38],"RMS":[40,233],"trials.":[42],"METHODS:":[43],"In":[44,101],"study,":[46],"systematic":[48],"literature":[49],"review":[50],"was":[51],"conducted":[52,70],"to":[53,71,203,236,242],"identify":[54],"BVL":[55,79,109,221,229],"results":[56,180],"from":[57],"randomized":[58],"controlled":[59],"trials":[60],"DMTs":[62,77,104,252],"RMS.":[64],"Indirect":[65],"treatment":[66],"comparisons":[67],"(ITCs)":[68],"were":[69,184],"estimate":[72],"the":[73,102,176,190,198,248],"relative":[74],"efficacy":[75],"using":[80],"two":[81,113],"approaches:":[82],"model-based":[84],"meta-analysis":[85,98],"(MBMA)":[86],"with":[87,106,187],"adjustment":[88],"for":[89,200,212],"measurement":[90],"timepoint":[91],"and":[92,95,160,173,205,241],"DMT":[93],"dosage,":[94],"network":[97],"(NMA).":[99],"RESULTS:":[100],"MBMA,":[103],"associated":[105],"significantly":[107],"reduced":[108],"versus":[110],"placebo":[111],"at":[112],"years":[114],"included":[115,197],"fingolimod":[116],"(mean":[117],"difference":[118],"[MD]":[119],"=":[120,126,132,136,142,146,152,156,163,167],"0.25;":[121],"95%":[122,134,144,154,165],"confidence":[123],"interval":[124],"[CI]":[125],"0.15":[127],"-":[128,138,148,158,169],"0.36),":[129],"ozanimod":[130],"(MD":[131,141,151,162],"0.26;":[133],"CI":[135,145,155,166],"0.12":[137],"0.41),":[139],"teriflunomide":[140],"0.38;":[143,153],"0.20":[147],"0.55),":[149],"alemtuzumab":[150],"0.10":[157],"0.67)":[159],"ponesimod":[161],"0.71;":[164],"0.48":[168],"0.95),":[170],"whereas":[171],"interferons":[172],"natalizumab":[174],"performed":[175],"most":[177],"poorly.":[178],"The":[179],"NMA":[182],"analysis":[183],"generally":[185],"comparable":[186],"those":[188],"MBMA.":[191],"CONCLUSIONS:":[192],"Limitations":[193],"these":[195],"analyses":[196],"potential":[199],"confounding":[201],"due":[202],"pseudoatrophy,":[204],"lack":[207],"long-term":[209],"data":[211],"BVL.":[213,255],"Our":[214],"findings":[215],"suggest":[216],"that":[217],"important":[218,235],"differences":[219],"may":[222],"exist":[223],"between":[224],"DMTs.":[225],"Continued":[226],"investigation":[227],"studies":[231],"complement":[237],"traditional":[238],"endpoints,":[240],"foster":[243],"better":[245],"understanding":[246],"mechanisms":[249],"by":[250],"which":[251],"can":[253],"slow":[254]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-10-09T00:00:00"}